Tag: Centinel Spine
Silony Medical completes acquisition of Centinel Spine’s Global Fusion Business
Silony Medical has announced that it has completed the acquisition of Centinel Spine's Global Fusion Business and related assets.
The completed transaction includes all of...
Centinel Spine announces 500th procedure with prodisc C Vivo and prodisc...
Centinel Spine has announced the completion of the 500th procedure in the USA with its latest US Food and Drug Administration (FDA)-approved total disc replacement...
New CPT code now effective for second level of lumbar total...
Centinel Spine has revealed that, from 1 January 2023, providers are able to utilise a new Current Procedural Terminology (CPT) code when performing two-level lumbar...
Centinel Spine announces first commercial use of prodisc C SK cervical...
Centinel Spine has announced the first implantation of its prodisc C SK cervical total disc replacement (TDR) product. In July 2022, the company received US...
Centinel Spine announces prodisc C Vivo cervical total disc replacement milestone
Centinel Spine has announced the completion of the 100th procedure in the USA using its prodisc C Vivo cervical total disc replacement (TDR) device.
Kevin Rutz, an...
First commercial use of prodisc C Vivo in Western US
Centinel Spine has announced the first implantation of its prodisc C Vivo cervical total disc replacement (TDR) product in the Western US. The procedure was undertaken by...
Centinel Spine announces full commercial launch of FORTOS-C anterior cervical plating...
Centinel Spine has expanded its cervical solutions portfolio following the full commercial launch of its FORTOS-C anterior cervical plating system.
The FORTOS-C plate is a titanium anterior...
Further three prodisc cervical total disc replacement devices granted FDA approval
Centinel Spine has announced US Food and Drug Administration (FDA) pre-market application (PMA) approval for one-level indications for three additional cervical total disc replacement...
New CPT add-on code accepted for second level of lumbar total...
In an effort to increase the availability of two-level lumbar total disc replacement (TDR) to individuals experiencing degeneration of the intervertebral discs, the American...
Study supports clinical effectiveness of STALIF C-Ti integrated interbody system
The STALIF C-Ti integrated cage-screw implant (Centinel Spine) has demonstrated statistically significant and clinically meaningful improvements in all available patient reported outcome scores out...
New study demonstrates long-term efficacy of prodisc L total disc replacement
Centinel Spine has announced findings of a new study that it says strongly support the long-term safety and effectiveness of its prodisc L total disc replacement...
Centinel Spine announces first implant of prodisc L Lumbar total disc...
Centinel Spine has announced the first implantation of newly available angled endplates in the USA for the prodisc L Lumbar Total Disc Replacement System....
Centinel Spine announces 3,500 3D-printed devices successfully implanted
Centinel Spine, a privately-held spine company focused on anterior column reconstruction, has announced its novel FLX technology platform of 3D-printed porous titanium interbody devices.
The...
Centinel Spine announces approval for the manufacturing transfer of prodisc technology
Centinel Spine has announced US Food and Drug Administration (FDA) approval for the manufacturing transfer of both the prodisc C Cervical Total Disc Replacement...
Centinel Spine receives FDA approval for two-level indications of prodisc L
Centinel Spine has announced US Food and Drug (FDA) approval of two-level indications for the prodisc L lumbar total disc replacement (TDR) system.
Centinel...
Enrolment for two-level prodisc patient study begins
Enrolment has begun in the USA for a new patient study featuring two artificial cervical discs designed by spinal device manufacturer Centinel Spine, the...
Centinel Spine announces IDE approval of two different ProDisc C devices
According to a press release, Centinel Spine has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate...